Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
42 participants
INTERVENTIONAL
2026-01-23
2027-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Walking Exercise on Sleep Quality in Sedentary Healthy Adults
NCT04427696
The Effect of Exercise on Sleep Quality in Elderly Individuals
NCT07181460
Relationships Between Exercise and Emotion Regulation on Physical Activity in Frail Older Adults
NCT03514160
Physical Fitness, Sleep Quality, Dynamic Balance and Exercise in Aged People
NCT06646380
Resistance Exercise and Sleep Quality by Chronotype
NCT07234812
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
* "Active" group
* "Inactive-sedentary" group
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
"Inactive-sedentary" group
inactive participants that realize 3 experimental conditions: evening exercise, morning exercise and control (no-exercise).
Aerobic Exercise
The physical exercise consist of treadmill running at 65% of the maximal aerobic speed (MAP) until exhaustion (time to exhaustion exercise type).
"Active" group
endurance athletes that realize 3 experimental conditions: evening exercise, morning exercise and control (no-exercise).
Aerobic Exercise
The physical exercise consist of treadmill running at 65% of the maximal aerobic speed (MAP) until exhaustion (time to exhaustion exercise type).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Aerobic Exercise
The physical exercise consist of treadmill running at 65% of the maximal aerobic speed (MAP) until exhaustion (time to exhaustion exercise type).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Group "Active": Regular exercise (athletes that are specialized in aerobic exercise, with more than 300 minutes per-week over 6 months and practice at regional level).
Exclusion Criteria
* Have a diagnosed mental health condition requiring treatment
* Have renal, respiratory, cardiovascular or neuromuscular disease medically diagnosed.
* Be pregnant or breastfeeding
18 Years
30 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Saint Etienne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Frédéric ROCHE, PhD
Role: PRINCIPAL_INVESTIGATOR
CHU SAINT-ETIENNE
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chu Saint-Etienne
Saint-Etienne, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025-A00957-42
Identifier Type: OTHER
Identifier Source: secondary_id
25CH122
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.